human studies bpc 157 The Real BPC-157 Story: 544 Papers, 30 Subjects, 50 Million Views FDA advisory committee votes to

Peer-reviewed research describes SLU-PP-332 as an ERR// pan-agonist, with the highest reported potency for ERR

It has been used to treat some nutrition based disease such as dementia, rheumatoid arthritis and exerts neuronal protection by promoting regeneration to injured nerves

That result is attributed to the ingredient-level study and does not represent a whole-product outcome claim for BPC-157 Ultra Probiotic

[DOI] [PubMed] [Google Scholar] 57.Gould HP, Weiner DA, Tomaszewski PM, Parks BG, Abbasi P, Fillar AL: High-strength suture tape augmentation improves cyclic gap formation in transosseous patellar tendon repair: A biomechanical study

PCD is similarly neutrophilic with neutrophil activity, neutrophil elastase, and IL-8 all increased in PCD patients (Nussstein et al., 2026)